전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
tahun 2011 food and drud administration (fda) menetapkan ruxolitinib sebagai pengobatan myelofibrosis pada resiko menengah sampai tinggi
roxulitinib belongs to the class of janus kinase inhibitor drugs (jak) 1 and 2 jak function to activate signal transducers and transcription activators (stats) which result in the activation of jak stat signals and have an impact on cell differentiation, proliferation and survival
마지막 업데이트: 2023-06-26
사용 빈도: 1
품질:
the sample in this research was taken from a doctor's prescription at the mini seven pharmacy pharmacy for the february-june 2023 period, consisting of 117 doctor's prescriptions. based on the data taken in accordance with the requirements for completeness of prescription administration with the percentage of doctor's name 38.46%, sip number 23.08%, address of doctor's practice 88.03%, date of writing of prescription and r/ mark 81.20%, drug name 100, 00%, how to use 63.25%, drug dosage 28.21%, patient name 100%, patient age 79.49%, patient address 75.21%, doctor's initials 53.58%. based on the screening data for prescription administration completeness requirements at the mini seven pharmacy pharmacy that meet the requirements based on permenkes no. 73 of 2016 as much as 5.12% and the completeness of prescriptions at the mini sevene pharmacy pharmacy for the february-june 2023 period based on the screening of administrative completeness requirements is mostly not in accordance with ri minister of health no. 73 of 2016.
마지막 업데이트: 2023-08-23
사용 빈도: 1
품질: